cilostazol has been researched along with Necrosis in 6 studies
Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It is unknown whether cilostazol pretreatment reduces postprocedural myonecrosis (PPMN)." | 9.15 | A randomized study assessing the effects of pretreatment with cilostazol on periprocedural myonecrosis after percutaneous coronary intervention. ( Jeon, DW; Kim, BK; Ko, YG; Oh, SJ; Yang, JY; Yoon, SJ, 2011) |
| "Postoperative enteral administration of cilostazol increased blood flow and decreased the total area of necrosis of avulsed cutaneous flaps of rat limbs." | 7.88 | Effect of cilostazol in experimental model of degloving injuries in rat limbs. ( Pazio, A; Salles Junior, GS; Santos, VB, 2018) |
| "It is unknown whether cilostazol pretreatment reduces postprocedural myonecrosis (PPMN)." | 5.15 | A randomized study assessing the effects of pretreatment with cilostazol on periprocedural myonecrosis after percutaneous coronary intervention. ( Jeon, DW; Kim, BK; Ko, YG; Oh, SJ; Yang, JY; Yoon, SJ, 2011) |
| "Postoperative enteral administration of cilostazol increased blood flow and decreased the total area of necrosis of avulsed cutaneous flaps of rat limbs." | 3.88 | Effect of cilostazol in experimental model of degloving injuries in rat limbs. ( Pazio, A; Salles Junior, GS; Santos, VB, 2018) |
| "This study evaluated the possible protective effects of cilostazol against myonecrosis in dystrophic diaphragm muscle in vivo, focusing on oxidative stress, the inflammatory response and angiogenesis." | 3.83 | Beneficial cilostazol therapeutic effects in mdx dystrophic skeletal muscle. ( Cagnon, VH; de Faria, FM; Fogaça, AR; Hermes, Tde A; Kido, LA; Macedo, AB; Minatel, E; Moraes, LH, 2016) |
| "Cilostazol treatment seemed to increase the viability of TRAM flap, especially when administered as adjuvant therapy." | 1.46 | The protective effect of cilostazol on transverse rectus abdominis myocutaneous flap in rats. ( Altun, S; İnözü, E; Orhan, E; Özdemir, A, 2017) |
| "Cilostazol is an antiplatelet agent that can induce the regression of atherosclerosis." | 1.40 | Carotid plaque characteristics on magnetic resonance plaque imaging following long-term cilostazol therapy. ( Narumi, S; Ohba, H; Oura, K; Sasaki, M; Terayama, Y; Uwano, I; Yamaguchi Oura, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pazio, A | 1 |
| Santos, VB | 1 |
| Salles Junior, GS | 1 |
| Coelho da Mota, DS | 1 |
| Sicuro, FL | 1 |
| Resende, AC | 1 |
| De Moura, RS | 1 |
| Bottino, DA | 1 |
| Bouskela, E | 1 |
| Yamaguchi Oura, M | 1 |
| Sasaki, M | 1 |
| Ohba, H | 1 |
| Narumi, S | 1 |
| Oura, K | 1 |
| Uwano, I | 1 |
| Terayama, Y | 1 |
| Hermes, Tde A | 1 |
| Macedo, AB | 1 |
| Fogaça, AR | 1 |
| Moraes, LH | 1 |
| de Faria, FM | 1 |
| Kido, LA | 1 |
| Cagnon, VH | 1 |
| Minatel, E | 1 |
| Özdemir, A | 1 |
| Orhan, E | 1 |
| Altun, S | 1 |
| İnözü, E | 1 |
| Kim, BK | 1 |
| Oh, SJ | 1 |
| Yoon, SJ | 1 |
| Jeon, DW | 1 |
| Ko, YG | 1 |
| Yang, JY | 1 |
1 trial available for cilostazol and Necrosis
| Article | Year |
|---|---|
A randomized study assessing the effects of pretreatment with cilostazol on periprocedural myonecrosis after percutaneous coronary intervention.
Topics: Aged; Angina, Stable; Angioplasty, Balloon, Coronary; Cilostazol; Creatine Kinase, MB Form; Female; | 2011 |
5 other studies available for cilostazol and Necrosis
| Article | Year |
|---|---|
Effect of cilostazol in experimental model of degloving injuries in rat limbs.
Topics: Animals; Cilostazol; Degloving Injuries; Disease Models, Animal; Humans; Laser-Doppler Flowmetry; Lo | 2018 |
Effects of açaí and cilostazol on skin microcirculation and viability of TRAM flaps in hamsters.
Topics: Animals; Capillaries; Cilostazol; Cricetinae; Disease Models, Animal; Drug Evaluation, Preclinical; | 2018 |
Carotid plaque characteristics on magnetic resonance plaque imaging following long-term cilostazol therapy.
Topics: Aged; Carotid Artery Diseases; Cilostazol; Female; Fibrosis; Humans; Imaging, Three-Dimensional; Int | 2014 |
Beneficial cilostazol therapeutic effects in mdx dystrophic skeletal muscle.
Topics: Animals; Body Weight; Cilostazol; Creatine Kinase; Diaphragm; Female; Male; Mice; Mice, Inbred mdx; | 2016 |
The protective effect of cilostazol on transverse rectus abdominis myocutaneous flap in rats.
Topics: Animals; Cilostazol; Graft Survival; Models, Animal; Myocutaneous Flap; Necrosis; Phosphodiesterase | 2017 |